image
Healthcare - Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - TOTAL LIABILITIES

Total Liabilities KROS - Keros Therapeutics, Inc.

image
37.8 M
LAST VALUE
76.94%
2 YEAR CAGR
20.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR